Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Read more about Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma.
Current concepts in bronchioloalveolar carcinoma biology. Read more about Current concepts in bronchioloalveolar carcinoma biology.
The cancer and leukemia group B pharmacology and experimental therapeutics committee: a historical perspective. Read more about The cancer and leukemia group B pharmacology and experimental therapeutics committee: a historical perspective.
Activities and accomplishments of the cancer and leukemia group B genitourinary committee. Read more about Activities and accomplishments of the cancer and leukemia group B genitourinary committee.
Evaluation of toxicity following electrically mediated interleukin-12 gene delivery in a B16 mouse melanoma model. Read more about Evaluation of toxicity following electrically mediated interleukin-12 gene delivery in a B16 mouse melanoma model.
Phase II trial of celecoxib in prostate-specific antigen recurrent prostate cancer after definitive radiation therapy or radical prostatectomy. Read more about Phase II trial of celecoxib in prostate-specific antigen recurrent prostate cancer after definitive radiation therapy or radical prostatectomy.
Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Read more about Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group. Read more about A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group.
Avidity-mediated enhancement of in vivo tumor targeting by single-chain Fv dimers. Read more about Avidity-mediated enhancement of in vivo tumor targeting by single-chain Fv dimers.
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Read more about Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.